Bioharvest Sciences (BHST) Current Deferred Revenue (2023 - 2026)
Bioharvest Sciences' Current Deferred Revenue was $415,000 in the quarter ended Jun 30, 2026, down 58.1% from $990,000 a year earlier and down 12.4% from the prior quarter.
Powered by 
Analysis
Bioharvest Sciences (BHST) Current Deferred Revenue (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Current Deferred Revenue at Bioharvest Sciences came in at $492,000, down 45.7% from the prior year.
- In earlier years, Current Deferred Revenue was $906,000 in the year ended Dec 31, 2024 (+26.2%) and $718,000 in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Current Deferred Revenue in data going back to the quarter ended Dec 31, 2023.
- Compared with a year earlier, Current Deferred Revenue has declined for three straight quarters, with an average decline of 22.2% over the last five quarters.
- Per Business Quant data, BHST's Current Deferred Revenue in the three quarters before the quarter ended Jun 30, 2026 was $474,000 (quarter ended Mar 31, 2026), $492,000 (quarter ended Dec 31, 2025) and $438,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bioharvest Sciences | 27.25 Mn | -43.13 Mn | 5.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 415,000.00 |
| Mar 31, 2026 | 474,000.00 |
| Dec 31, 2025 | 492,000.00 |
| Sep 30, 2025 | 438,000.00 |
| Jun 30, 2025 | 990,000.00 |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 906,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Dec 31, 2023 | 718,000.00 |
API Access
Bioharvest Sciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BHST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BHST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BHST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();